Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating rifaximin added to oral rehydration versus oral rehydration alone in children with acute diarrhea, and the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifaximin (rifaximin)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Diarrhea, Gastroenteritis | Phase 4 | Status: RECRUITING